Coalesce Capital has announced it has participated in a recapitalization of Examinetics.
Examinetics, founded in 2004 and based in Overland Park, Kan., is a provider of mobile occupational health screening services, tests and data management.
Coalesce, based in New York, is a middle market private equity firm focused on investing in human capital and technology-enabled business services companies. The firm primarily makes control investments in companies with at least $5 million of EBITDA and $25 million of revenue.
Coalesce partnered with Freedom 3 Capital, an existing Examinetics shareholder, and management for the recapitalization.
Terms of the investment were not disclosed.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Automotive / EVs, Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- ChartPrime. Elevate your Trading Game with ChartPrime. Access Here.
- BlockOffsets. Modernizing Environmental Offset Ownership. Access Here.
- Source: https://www.thehealthcareinvestor.com/2023/08/articles/healthcare-services-investing/healthcare-life-sciences-private-equity-deal-tracker-coalesce-capital-recapitalizes-examinetics/